Market Overview:
The global host cell protein testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for biologics and rising number of clinical trials. In addition, the growing awareness about quality control and safety measures is also contributing to the growth of this market. The PCR-based assays segment is expected to dominate the global host cell protein testing market during the forecast period owing to its high accuracy and sensitivity. The ELISA-based assays segment is projected to grow at a higher CAGR than other segments during the forecast period, owing to its low cost and easy availability. Geographically, North America dominates the global host cell protein testing market followed by Europe and Asia Pacific region respectively; however, Asia Pacific region is projectedto grow at a higher CAGR duringthe forecastperiod due tobusiness expansion opportunities in countries such as Chinaand India .
Product Definition:
Host Cell Protein Testing is a laboratory procedure that is used to detect and measure the amount of host cell proteins in a biological sample. Host cell proteins are proteins that are produced by cells other than the target cells that are being targeted for destruction by certain types of therapies, such as monoclonal antibodies. The presence of these proteins can interfere with the effectiveness of the therapy, so it is important to test for their presence and measure their levels.
PCR-based Assays:
Polymerase Chain Reaction (PCR) is a technique that uses DNA as a probe to identify and amplify specific genetic sequences. PCR-based assays are used for the detection of infectious diseases, cancer, and inherited disorders in host cells. The technology has been applied successfully in various fields such as genomics, proteomics, diagnostics & drug discovery research along with environmental studies.
ELISA-based Assays:
ELISA-based assay is used for the detection of a wide range of infectious diseases such as HIV, HCV, and TB. It also finds application in the diagnosis of cancer and autoimmune diseases. ELISA stands for Enzyme-Linked Immunosorbent Assay. This assay is considered to be one of the most sensitive tests available today with an accuracy rate greater than 90%.
Application Insights:
The others segment held the largest market share in 2017 and includes commercial laboratories, diagnostic centers and hospitals. The growth of this segment can be attributed to the increasing demand for rapid, accurate and sensitive testing methods for Host Cell Protein (HCP) related infections.
Hospital application is expected to witness lucrative growth over the forecast period owing to an increase in prevalence of chronic diseases such as cancer, diabetes mellitus among other infectious diseases that pose a threat to human life. Furthermore, an increase in number of hospital-acquired diagnostics machines is anticipated to boost revenue generation from this sector during future years.
Increasing investment by governments across various regions towards advancement of medical science has resulted in development of advanced diagnostic techniques that help detect even smallest microorganisms with high sensitivity thereby aiding diagnosis at early stages when compared with traditional microscopy based tests which are limited only by resolution power available within a microscope platform.
Regional Analysis:
North America dominated the global host cell protein testing market in 2017. This can be attributed to the presence of a large number of players, advanced healthcare infrastructure, and high adoption rate for novel diagnostic technologies. Moreover, increasing prevalence of cancer is also expected to drive regional growth over the forecast period. For instance, according to data published by American Cancer Society in 2018, approximately 1 million new cases were estimated to be diagnosed in U.S., with most occurring among women (1). Such statistics highlight the need for early diagnosis which is further fueling regional growth.
Asia Pacific region is anticipated to witness lucrative growth during the forecast period owing to rising disposable income and growing awareness about various types of tests offered by laboratories coupled with availability & accessibility of these tests at affordable prices as comparedtto developed regions (2).
Growth Factors:
- Increasing demand for biologics and biosimilars
- Rising prevalence of chronic diseases
- Technological advancements in host cell protein testing methods
- Growing number of contract research organizations (CROs) and clinical laboratories
- Increasing funding for life sciences research
Scope Of The Report
Report Attributes
Report Details
Report Title
Host Cell Protein Testing Market Research Report
By Type
PCR-based Assays, ELISA-based Assays
By Application
Research Institute, Hospital, Others
By Companies
GE Healthcare, Thermo Fisher Scientific, Charles River, Cisbio Bioassays, Cygnus Technologies, Bio-Rad Laboratories, Enzo Life Sciences, BioGenes, ForteBio (Pall), Molecular Devices
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
124
Number of Tables & Figures
87
Customization Available
Yes, the report can be customized as per your need.
Global Host Cell Protein Testing Market Report Segments:
The global Host Cell Protein Testing market is segmented on the basis of:
Types
PCR-based Assays, ELISA-based Assays
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research Institute, Hospital, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GE Healthcare
- Thermo Fisher Scientific
- Charles River
- Cisbio Bioassays
- Cygnus Technologies
- Bio-Rad Laboratories
- Enzo Life Sciences
- BioGenes
- ForteBio (Pall)
- Molecular Devices
Highlights of The Host Cell Protein Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- PCR-based Assays
- ELISA-based Assays
- By Application:
- Research Institute
- Hospital
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Host Cell Protein Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Host cell protein testing is a process that allows for the detection and quantification of proteins in a sample. This can be used to help identify potential sources of contamination or to assess the health of a particular organism.
Some of the major players in the host cell protein testing market are GE Healthcare, Thermo Fisher Scientific, Charles River, Cisbio Bioassays, Cygnus Technologies, Bio-Rad Laboratories, Enzo Life Sciences, BioGenes, ForteBio (Pall), Molecular Devices.
The host cell protein testing market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Host Cell Protein Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Host Cell Protein Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Host Cell Protein Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Host Cell Protein Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Host Cell Protein Testing Market Size & Forecast, 2018-2028
4.5.1 Host Cell Protein Testing Market Size and Y-o-Y Growth
4.5.2 Host Cell Protein Testing Market Absolute $ Opportunity
Chapter 5 Global Host Cell Protein Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Host Cell Protein Testing Market Size Forecast by Type
5.2.1 PCR-based Assays
5.2.2 ELISA-based Assays
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Host Cell Protein Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Host Cell Protein Testing Market Size Forecast by Applications
6.2.1 Research Institute
6.2.2 Hospital
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Host Cell Protein Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Host Cell Protein Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Host Cell Protein Testing Analysis and Forecast
9.1 Introduction
9.2 North America Host Cell Protein Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Host Cell Protein Testing Market Size Forecast by Type
9.6.1 PCR-based Assays
9.6.2 ELISA-based Assays
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Host Cell Protein Testing Market Size Forecast by Applications
9.10.1 Research Institute
9.10.2 Hospital
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Host Cell Protein Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Host Cell Protein Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Host Cell Protein Testing Market Size Forecast by Type
10.6.1 PCR-based Assays
10.6.2 ELISA-based Assays
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Host Cell Protein Testing Market Size Forecast by Applications
10.10.1 Research Institute
10.10.2 Hospital
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Host Cell Protein Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Host Cell Protein Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Host Cell Protein Testing Market Size Forecast by Type
11.6.1 PCR-based Assays
11.6.2 ELISA-based Assays
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Host Cell Protein Testing Market Size Forecast by Applications
11.10.1 Research Institute
11.10.2 Hospital
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Host Cell Protein Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Host Cell Protein Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Host Cell Protein Testing Market Size Forecast by Type
12.6.1 PCR-based Assays
12.6.2 ELISA-based Assays
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Host Cell Protein Testing Market Size Forecast by Applications
12.10.1 Research Institute
12.10.2 Hospital
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Host Cell Protein Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Host Cell Protein Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Host Cell Protein Testing Market Size Forecast by Type
13.6.1 PCR-based Assays
13.6.2 ELISA-based Assays
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Host Cell Protein Testing Market Size Forecast by Applications
13.10.1 Research Institute
13.10.2 Hospital
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Host Cell Protein Testing Market: Competitive Dashboard
14.2 Global Host Cell Protein Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GE Healthcare
14.3.2 Thermo Fisher Scientific
14.3.3 Charles River
14.3.4 Cisbio Bioassays
14.3.5 Cygnus Technologies
14.3.6 Bio-Rad Laboratories
14.3.7 Enzo Life Sciences
14.3.8 BioGenes
14.3.9 ForteBio (Pall)
14.3.10 Molecular Devices
